Журнал European Student Scientific Journal 2310-3094 Общество с ограниченной ответственностью "Издательский Дом "Академия Естествознания" ART-376 ACTUAL PHARMACOLOGICAL BIOTECHNOLOGICAL INNOVATIONS TO IMPROVE THE QUALITY OF PATIENT’S LIFE THERAPEUTIC AND SURGICAL PROFILE Karnaukh E.V. ella69k@mail.ru Polikov G.O. ella69k@mail.ru Zavgorodniy A.S. ella69k@mail.ru The Kharkiv National Medical University The Kharkiv National Medical University 12 02 2016 2 9 9 This is an open-access article distributed under the terms of the CC BY 4.0 license. https://sjes.esrae.ru/ru/article/view?id=376

Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).

Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).

 genetic engineering pharmaceuticals Subalin Roferon-А IFN Altevir genetic engineering pharmaceuticals Subalin Roferon-А IFN Altevir